Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 5 Share on Twitter Printer Friendly Page More Sharing
General News   

'Blatant Hypocrisy': Trump Heralds Covid-19 Drugs He Took Made Possible

Author 40790
Follow Me on Twitter     Message Susan Lee Schwartz
Become a Fan
  (23 fans)

Although the monoclonal antibodies infused into Trump were not made from or in fetal cells, Regeneron did develop that treatment with the help of a long-lived line of cells established from the kidneys of a fetus electively aborted in the Netherlands around 1972. The company relied on those widely used cells, known HEK-293 cells, to make mimics of the coronavirus spike protein. The antiviral drug Remdesivir, which Trump took last week, was also developed with those same cell lines. The New York Times reports at least 2 other pharmas working on a coronavirus vaccine also rely on the cells, and Johnson & Johnson is testing its vaccine using another cell line derived from fetal tissue. 

Read the rest of the story HERE:

At www.commondreams.org

 

Rate It | View Ratings

Susan Lee Schwartz Social Media Pages: Facebook Page       Twitter Page       Linked In Page       Instagram Page

I began teaching in 1963,; Ba and BS in Education -Brooklyn College. I have the equivalent of 2 additional Master's, mainly in Literacy Studies and Graphic Design. I was the only seventh grade teacher of English from 1990 -1999 at East Side (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: